Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

  • Dansk
  • NL
  • EN
  • FI
  • FR
  • DE
  • EL
  • IT
  • NO
  • PL
  • PT
  • RO
  • SL
  • ES
  • SV

The European Parliament demands stricter regulation of conflicts of interest at EU's food safety authority

In reaction to numerous conflicts of interest scandals at the European Food Safety Authority (EFSA), the European Parliament today voted for a resolution1 to ban scientists with ties to the agriculture and food industries from working at the agency. The Parliament urges the EFSA to introduce “a two-year cooling-off period to all material interests related to the commercial agrifood sector”, a measure which would considerably improve the food agency's tarnished reputation and compromised integrity.

The European Parliament called the existing procedure for screening EFSA experts' interests “burdensome”, “subject to criticism”, and inadequate to “dispel fears about the Authority’s expert impartiality”, and while it did acknowledge the “progress” that a 2011 reform policy had brought about, it nevertheless questioned this attempt at reform's “credibility and effectiveness”.

Parliament had postponed the agency's budget discharge in 2012 because of conflicts of interest scandals and asked to the agency to reform. However, Corporate Europe Observatory (CEO)'s report “Unhappy Meal”, published in October 2013, revealed that some 59% of EFSA's scientific panels members still had direct or indirect links to companies whose activities fell under EFSA's remit. In other words, the report shows almost two thirds of EFSA's panel scientists still have conflicts of interest and cannot be considered independent from the sector they are regulating.

This report argues that the main loophole in EFSA's current independence policy is it only assesses its experts' interests according to the specific panel's narrow remit (for instance: additives, feed, sweeteners, GMOs or pesticides) instead of the agency's broad mission (food and agriculture at large); whereas most companies in the industry have many more than one field of activity. This narrow assessment enables the agency to work with scientists with financial ties to all the big names in the food industry (mainly in the form of research funding and consultancy contracts) while seeming to preserve its independence.

Such a loophole would be largely closed by European Parliament's latest demand, even though CEO considers the two year cooling-off period too short.

Martin Pigeon, researcher and campaigner at CEO, said: “It is unacceptable that the food industry has a say in the public risk assessment of its products. This vote by the European Parliament is a crucial step for food safety in Europe. A cooling-off period, if correctly implemented by the agency, will keep scientists with such conflicts of interest at bay and considerably strengthen the agency's integrity.”

However, the agency's management is opposed to such an idea. While it is once again revising its independence policy (spending €50.000 to commission a report on the issue to consultancy Deloitte), recent statements by the newly appointed Director of EFSA, Bernard Url, suggest meaningful change will not happen. Speaking at the meeting of EFSA's Stakeholder Consultative Platform on March 26, Mr Url said: “Making the conflict of interest rules stricter is not the way forward”.

As CEO's Martin Pigeon says, “Strong scrutiny will be needed to make sure that the EFSA does implement the Parliament's demands.”

  • 1. Link to the resolution: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&reference=A7-2... The text of the resolution, drafted by Finish conservative MEP Petri Sarvamaa and amended by Green MEP Bart Staes on this point, was already supported by all political groups in the Parliament's Budget Control Committee. Accompanying the granting of the agency's budget discharge, it was voted today with an overwhelming majority.
Related issues: 
 

The official EU assessment of glyphosate was based on unpublished studies owned by industry. Seven months later, the pesticide industry still fights disclosure and, so far, successfully. We obtained a copy of their arguments.

The European Commission proposal on scientific criteria defining endocrine disruptors (EDCs) is the latest dangerous outgrowth of a highly toxic debate. The chemical lobby, supported by certain Commission factions (notably DG SANTE and the Secretary-General) and some member states (UK and Germany), has put significant obstacles in the way of effective public health and environment regulation.

This May is dense on the EU chemicals regulation front. Crunch time for two major files: the European Commission needs to publish the identification criteria for endocrine disrupting chemicals, and together with EU States must decide how, or not, renew the market approval of glyphosate, an herbicide produced and defended by Monsanto. Last week, the Professor Alan Boobis happened to be involved in both.

Demonstrating the problematic symbiosis between corporate interests and EU institutions, the same lobbying consultancies often get hired by both.

The Commission is set to announce its proposal for a new ‘mandatory’ lobby transparency register next week. During the Summer, the Commission made public the input it received via consultation on the topic. Besides a general call from public and civil society to boost transparency systems, they also showed corporate lobby groups and trade associations’ spin, promoting transparency values while recommending limited implementation, loopholes and toothless management.

CEO's immediate reaction to the latest revelations from the team behind the Panama Leaks.

The European Commission is about to propose a regulation on acrylamide, a dangerous contaminant formed in many starchy foods when cooked at high temperatures. But the regulation itself consists in referring to codes of best practices developed by lobby groups representing the food industry.

A new report on the Comprehensive Economic Trade Agreement (CETA) reveals how the trade deal could make EU member states vulnerable to costly lawsuits from North American investors that threaten public interest.

 
 
 
 
 
-- placeholder --
 
 
 

The corporate lobby tour